A first-in-human study of NXT007, a next-generation, activated factor VIII-mimetic bispecific antibody, in healthy participants.

Saved in:
Bibliographic Details
Title: A first-in-human study of NXT007, a next-generation, activated factor VIII-mimetic bispecific antibody, in healthy participants.
Authors: Sambe T; Clinical Research Center for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Department of Clinical Pharmacology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan., Miwa T; Chugai Pharmaceutical Co, Ltd, Tokyo, Japan., Yoneyama K; Chugai Pharmaceutical Co, Ltd, Tokyo, Japan., Ishida T; Chugai Pharmaceutical Co, Ltd, Tokyo, Japan., Yamazaki T; Clinical Research Center for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Shima M; Thrombosis and Hemostasis Research Center, Nara Medical University, Kashihara, Japan. Electronic address: mshima@naramed-u.ac.jp.
Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2025 Oct; Vol. 23 (10), pp. 3098-3110. Date of Electronic Publication: 2025 Jun 17.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836 (Electronic) Linking ISSN: 15387836 NLM ISO Abbreviation: J Thromb Haemost Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40554054
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A first-in-human study of NXT007, a next-generation, activated factor VIII-mimetic bispecific antibody, in healthy participants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sambe+T%22">Sambe T</searchLink>; Clinical Research Center for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Department of Clinical Pharmacology, Graduate School of Medicine, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Miwa+T%22">Miwa T</searchLink>; Chugai Pharmaceutical Co, Ltd, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoneyama+K%22">Yoneyama K</searchLink>; Chugai Pharmaceutical Co, Ltd, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ishida+T%22">Ishida T</searchLink>; Chugai Pharmaceutical Co, Ltd, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamazaki+T%22">Yamazaki T</searchLink>; Clinical Research Center for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shima+M%22">Shima M</searchLink>; Thrombosis and Hemostasis Research Center, Nara Medical University, Kashihara, Japan. Electronic address: mshima@naramed-u.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101170508%22">Journal of thrombosis and haemostasis : JTH</searchLink> [J Thromb Haemost] 2025 Oct; Vol. 23 (10), pp. 3098-3110. <i>Date of Electronic Publication: </i>2025 Jun 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101170508 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7836 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215387836%22">15387836 </searchLink><i>NLM ISO Abbreviation: </i>J Thromb Haemost <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40554054
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jtha.2025.06.013
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3098
    Titles:
      – TitleFull: A first-in-human study of NXT007, a next-generation, activated factor VIII-mimetic bispecific antibody, in healthy participants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sambe T
      – PersonEntity:
          Name:
            NameFull: Miwa T
      – PersonEntity:
          Name:
            NameFull: Yoneyama K
      – PersonEntity:
          Name:
            NameFull: Ishida T
      – PersonEntity:
          Name:
            NameFull: Yamazaki T
      – PersonEntity:
          Name:
            NameFull: Shima M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2025 Oct
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1538-7836
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Journal of thrombosis and haemostasis : JTH
              Type: main
ResultId 1